Morgan Stanley Raises CME Group (NASDAQ:CME) Price Target to $220.00
CME Group (NASDAQ:CME – Free Report) had its target price upped by Morgan Stanley from $215.00 to $220.00 in a research report report published on Thursday, Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock. Several other research analysts have also recently commented on the company. Rosenblatt Securities reissued […]
More Stories
Wedmont Private Capital Has $699,000 Stock Holdings in Novartis AG (NYSE:NVS)
Wedmont Private Capital increased its position in Novartis AG (NYSE:NVS – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com...
Patriot Financial Group Insurance Agency LLC Purchases 394 Shares of Truist Financial Co. (NYSE:TFC)
Patriot Financial Group Insurance Agency LLC grew its position in shares of Truist Financial Co. (NYSE:TFC – Free Report) by...
RFK Jr. Removes All Members of CDC Vaccine Advisory Panel
By Zachary Stieber All members of the committee that advises the Centers for Disease Control and Prevention are being replaced,...
ICE Sends Back 122 Illegal Immigrants to China
By Aldgra Fredly Some 122 illegal immigrants were deported to China on June 3 as part of the Department of...
Miracle Mile Advisors LLC Reduces Position in Intel Co. (NASDAQ:INTC)
Miracle Mile Advisors LLC lowered its position in Intel Co. (NASDAQ:INTC – Free Report) by 30.4% in the first quarter,...
Miracle Mile Advisors LLC Increases Position in Ecolab Inc. (NYSE:ECL)
Miracle Mile Advisors LLC raised its position in Ecolab Inc. (NYSE:ECL – Free Report) by 15.6% during the first quarter,...